Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetil
ABSTRACT Mycophenolate mofetil, an immunosuppressive agent, is frequently used following bone marrow and solid organ transplantation. Diarrhea is a commonly seen side effect of mycophenolate mofetil, which may necessitate colonic biopsy in some patients. The histologic changes found in this setting have been reported to mimic self-limited colitis, graft-vs-host disease or inflammatory bowel disease in isolated case reports, and could pose diagnostic and management difficulties. The goal of this study is to define the spectrum of histologic changes in colonic biopsies associated with mycophenolate mofetil usage. All solid organ transplant patients who received mycophenolate mofetil and underwent colonic biopsy for gastrointestinal symptoms from 1999 to 2007 were included in the study. Patients who did not receive mycophenolate mofetil were used as controls. Various histologic features including architectural distortion, apoptosis, inflammatory infiltrate, Paneth cell metaplasia and mucin depletion were subjectively evaluated and scored (scale: 0-3) by two independent reviewers in a blinded fashion. Forty solid organ transplant patients underwent colonic biopsy for gastrointestinal symptoms during the study period. Biopsies from 69% of patients on mycophenolate mofetil showed histologic changes. Apoptosis (41%) and architectural distortion (66%) were seen more frequently in patients receiving mycophenolate mofetil as compared to the control group (13%). The histologic changes in patients receiving mycophenolate mofetil were categorized as normal/near normal (31%), inflammatory bowel disease-like (28%), graft-vs-host disease-like (19%), ischemia-like (3%) and self-limited colitis-like (16%) changes. Of the controls, only one patient showed a graft-vs-host disease-like histologic pattern. In conclusion, histologic changes are frequently associated with mycophenolate mofetil use and can resemble self-limited colitis, graft-vs-host disease and inflammatory bowel disease leading to diagnostic difficulties. Increased awareness of the histologic spectrum of mycophenolate mofetil-induced changes is required by the pathologist to avoid diagnostic errors.
Full-textDOI: · Available from: Deborah D Proctor, Aug 21, 2014
- SourceAvailable from: Sean R Moore[Show abstract] [Hide abstract]
ABSTRACT: Mycophenolate mofetil (MMF) is an immunosuppressive medication utilized in the management of both autoimmune and solid organ transplant patients. Diarrhea is a common gastrointestinal side effect of MMF, but more severe forms of GI symptoms are described in renal transplant patients with a distinct pattern of histopathologic change, similar to graft-versus-host disease or Crohn's disease. This rare entity, commonly referred to as "MMF-related enterocolitis," has been described in adult patients, mostly in renal transplant patients, and in only two pediatric renal transplant patients. In previously reported cases, symptoms and abnormal histopathology improve with dose reduction of MMF. We describe a series of three pediatric patients with varied underlying disease process who presented with severe diarrhea and histopathologic findings characteristic of MMF-related enterocolitis, who share a novel finding of weight loss as a complication of MMF-related enterocolitis in pediatric patients.10/2012; 2012:624168. DOI:10.1155/2012/624168
Conference Paper: Layout optimization of spiral inductors in silicon chip for 5.7GHz WLAN[Show abstract] [Hide abstract]
ABSTRACT: A process to design and optimize the layout structure of inductors has been proposed. A set of inductors working at 5.7 GHz for WLAN has been designed based on using low resistivity silicon substrates and the 0.18 μm Cu/SiO<sub>2</sub> interconnect technology. The layout structures such as the inner core size, coil-width and coil-space of the inductors (0.2 nH to 11 nH) have been optimized. The optimized Q-value at 5.7 GHz is improved by a factor of 5 - 8 as compared to the tested Q-value of inductors using previous layout.ASIC, 2003. Proceedings. 5th International Conference on; 11/2003
- Revista medica de Chile 01/2010; 138(5). DOI:10.4067/S0034-98872010000500010 · 0.37 Impact Factor